Updated hourlyHourly refreshTue, Aug 11, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coastal Financial Corporation ("Coastal" or "the Company") (NASDAQ:CCB). Investors who purchased Coastal securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/CCB. Coastal Investigation Details On July 30, 2026, Coastal announced its second-quarter 2026 financial results, including a net loss of $42.1 million, or $(2.76) per diluted common share for the quarter, compared to net income of $12.0 million, or $0.78 per diluted common share in the prior quarter. The ..
Aug 10 · 17:02·PR-Inside
Finance · Energy
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bloom Energy Corporation (NYSE:BE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Bloom Energy securities between February 27, 2026 and July 8, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:bgandg.com/BE. Bloom Energy ..
Aug 10 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pharming Group N.V. ("Pharming Group" or "the Company") (NASDAQ:PHAR). Investors who purchased Pharming Group securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/PHAR. Pharming Group Investigation Details Pharming Group N.V. reported second-quarter 2026 financial results, including revenue of $90.2 million, a 3% year-over-year decline, and lowered its full-year 2026 revenue guidance to $375 million to $395 million, down from its prior guidance of $405 million to $425 million. The ..
Aug 10 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Rackspace Technology, Inc. (NASDAQ:RXT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Rackspace securities between May 7, 2026 and July 8, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:bgandg.com/RXT. Rackspace Case Details The ..
Aug 10 · 17:02·PR-Inside
Finance · Energy
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Americold Realty Trust, Inc. ("Americold" or "the Company") (NYSE:COLD). Investors who purchased Americold securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/COLD. Americold Investigation Details On July 23, 2026, Americold disclosed in a filing with the U.S. Securities and Exchange Commission that it had "entered into a Termination and Wind Down Agreement (the 'Agreement') with ADUSA Distribution, LLC, a subsidiary of Ahold Delhaize USA ('ADUSA Distribution'), pursuant to which ..
Aug 10 · 17:02·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group Inc. ("Replimune" or "the Company") (NASDAQ:REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/REPL. Replimune Investigation Details On July 28, 2026, the US Food and Drug Administration ("FDA") released briefing documents related to Replimune's lead trial for its drug vusolimogene oderparepvec, or RP1, for skin cancer. The briefing documents state the FDA has deemed the single-arm mid-stage study submitted by Replimune to ..
Aug 10 · 17:02·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Park Ha securities between December 27, 2024 and July 8, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the ..
Aug 10 · 17:02·PR-Inside
SaaS
COEUR D'ALENE, Idaho, Aug. 10, 2026 /PRNewswire/ -- Continuous Composites, Inc. ("CCI"), developer of the patented CF3D® advanced manufacturing platform, today announced that it has filed a patent infringement lawsuit against Anisoprint S.a.r.l. and Anisoprint 3D Printing Technology...
Aug 10 · 17:02·PR Newswire
In the wire
LOS ANGELES, Aug. 10, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Photronics, Inc. (PLAB) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PHOTRONICS, INC. (PLAB),...
Aug 10 · 17:02·PR Newswire
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. ("ADTRAN" or "the Company") (NASDAQ:ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/ADTN. ADTRAN Investigation Details On July 22, 2026, ADTRAN Holdings announced preliminary unaudited financial results for the second quarter of 2026, reporting expected revenue of $280 million to $282 million and a non-GAAP operating margin of approximately 3.5% to 4.0%, both below the Company's previously issued guidance of $283 ..
Aug 10 · 17:01·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Wix.com Ltd. (NASDAQ:WIX) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Wix securities between February 19, 2025 and May 12, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:bgandg.com/WIX. Wix Case Details According to ..
Aug 10 · 17:01·PR-Inside
Finance
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. ("Agios" or "the Company") (NASDAQ:AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site:bgandg.com/AGIO. Agios Investigation Details On July 21, 2026, Agios issued a press release "announcing topline results from the Phase 2 trial of tebapivat, an oral pyruvate kinase (PK) activator, in patients aged 16 years or older with sickle cell disease." The press release disclosed that "[t]he trial did not ..
Aug 10 · 17:01·PR-Inside